Havel & Partners has advised Genesis Private Equity Fund III on the sale of Quinta-Analytica to LVA Holding. Noerr advised the buyer on the deal.
Genesis Private Equity Fund III is a part of the Genesis Capital Group, which invests in small and medium-sized companies in the Czech Republic, Slovakia, Poland, Hungary, and Austria. LVA Holding is a part of the German group BBA Capital Partners. Quinta-Analytica is a provider of drug testing & bioanalytical services.
Havel & Partners’ team included Partner Vaclav Audes, Senior Associate Veronika Filipova, and Paralegal Filip Pavlik.
Noerr's team included Partner Barbara Kusak, Senior Associates Lucia Luptakova, Michal Janicek, and Filip Murar, Associate Barbora Safarikova, and Legal Advisors Pavel Hrdy and Matej Korduliak.
Editorial note: This article originally erroneously stated that Noer had advised the sellers on the deal. The information has now been corrected.